Alvespimycin inhibits heat shock protein 90 and overcomes imatinib resistance in chronic myeloid leukemia cell lines

HIGHLIGHTS

• who: Raquel Alves and collaborators from the Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology have published the paper: Alvespimycin Inhibits Heat Shock Protein 90 and Overcomes Imatinib Resistance in Chronic Myeloid Leukemia Cell Lines, in the Journal: Molecules 2023, 1210 of 30/Dec/2022
• what: 6 of 14 Since the study focused on HSP90 inhibition, the authors assessed the baselin levels of different HSP proteins in imatinibu2010sensitive and imatinibu2010resistant The authors evaluated the therapeutic potential of an HSP90 inhibitor, this study, the authors evaluated the therapeutic potential of an HSP90 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.